Clinical Trial Update: Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing the efficacy of candesartan in treating symptomatic heart failure among patients with diabetes and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: Takeda | Conditions: Heart Failure | Phase 3 | Status: COMPLETED